Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
Year: 2024
Type: review
Abstract: Advances in stem cell technology offer new possibilities for patients with untreated diseases and disorders. Stem cell-based therapy, which includes multipotent mesenchymal stem cells (MSCs), has recently become important in regenerative therapies. MSCs are multipotent progenitor cells that possess the ability to undergo in vitro self-renewal and differentiate into various mesenchymal lineages. MSCs have demonstrated promise in several areas, such as tissue regeneration, immunological modulation, anti-inflammatory qualities, and wound healing. Additionally, the development of specific guidelines and quality control methods that ultimately result in the therapeutic application of MSCs has been made easier by recent advancements in the study of MSC biology. This review discusses the latest clinical uses of MSCs obtained from the umbilical cord (UC), bone marrow (BM), or adipose tissue (AT) in treating various human diseases such as pulmonary dysfunctions, neurological disorders, endocrine/metabolic diseases, skin burns, cardiovascular conditions, and reproductive disorders. Additionally, this review offers comprehensive information regarding the clinical application of targeted therapies utilizing MSCs. It also presents and examines the concept of MSC tissue origin and its potential impact on the function of MSCs in downstream applications. The ultimate aim of this research is to facilitate translational research into clinical applications in regenerative therapies.
Source: Stem Cell Research & Therapy
Authors: Song Zhidu, Tao Ying, Jiang Rui, Zhang Chao
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Keywords: mesenchymal stem cells, regenerative medicine, stem cell therapy, umbilical cord-derived stem cells, bone marrow-derived stem cells, adipose-derived stem cells, tissue regeneration, immunomodulation, anti-inflammatory activity, wound healing, pulmonary dysfunction, neurological disorders, endocrine and metabolic diseases, cardiovascular disease, burns, reproductive disorders, targeted therapy, stem cell origin, clinical translation
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W4401865890
